AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Lenacapavir Sodium in Zambia
2 products registered with ZAMRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Lenacapavir Gilead 300 mg Film-Coated Tablets Film Coated Tablets | ZAMRA-HM-25-359 | Gilead Sciences Ireland UC | active | 3 Nov 2030 |
| Lenacapavir Gilead 464 mg Solution for Injection Solution for injection | ZAMRA-HM-25-360 | Gilead Sciences Ireland UC | active | 3 Nov 2030 |
Lenacapavir Sodium — ZAMRA Registration Details
ZAMRA (Zambia) has 2 registered products containing Lenacapavir Sodium, of which 2 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Lenacapavir Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.